Literature DB >> 2432397

Amino acid substitutions sufficient to convert the nontransforming p60c-src protein to a transforming protein.

J Y Kato, T Takeya, C Grandori, H Iba, J B Levy, H Hanafusa.   

Abstract

We have previously shown that Rous sarcoma virus variants that carry the cellular homolog (c-src) of the viral src gene (v-src) do not transform chicken embryo fibroblasts. We also have shown that replacement of sequences upstream or downstream from the BglI site of the cellular src gene with the corresponding regions of v-src restored transforming activity to the hybrid genes. Since there are only six amino acid changes between p60c-src and p60v-src within the sequences upstream from BglI, we constructed chimeric molecules involving v-src and c-src to determine the effect of each amino acid substitution on the biological activities of the gene product. We found that the change from Thr to Ile at position 338 or the replacement of a fragment of c-src containing Gly-63, Arg-95, and Thr-96 with a corresponding fragment of v-src containing Asp-63, Trp-95, and Ile-96 converted p60c-src into a transforming protein by the criteria of focus formation, anchorage-independent growth, and tumor formation in newborn chickens. These mutations also resulted in elevation of the protein kinase activity of p60c-src.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432397      PMCID: PMC367194          DOI: 10.1128/mcb.6.12.4155-4160.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  31 in total

1.  Restriction of the in vitro and in vivo tyrosine protein kinase activities of pp60c-src relative to pp60v-src.

Authors:  P M Coussens; J A Cooper; T Hunter; D Shalloway
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

2.  N-terminal deletions in Rous sarcoma virus p60src: effects on tyrosine kinase and biological activities and on recombination in tissue culture with the cellular src gene.

Authors:  F R Cross; E A Garber; H Hanafusa
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

3.  Rapid transformation of cells by Rous sarcoma virus.

Authors:  H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1969-06       Impact factor: 11.205

4.  Identification of a cellular protein substrate phosphorylated by the avian sarcoma virus-transforming gene product.

Authors:  E Erikson; R L Erikson
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

5.  Site-directed mutagenesis of the src gene of Rous sarcoma virus: construction and characterization of a deletion mutant temperature sensitive for transformation.

Authors:  D Bryant; J T Parsons
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

6.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

7.  DNA sequence of the viral and cellular src gene of chickens. II. Comparison of the src genes of two strains of avian sarcoma virus and of the cellular homolog.

Authors:  T Takeya; H Hanafusa
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

8.  Role of p60src kinase activity in the induction of neuroretinal cell proliferation by rous sarcoma virus.

Authors:  F Poirier; G Calothy; R E Karess; E Erikson; H Hanafusa
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

9.  Comparison between the viral transforming gene (src) of recovered avian sarcoma virus and its cellular homolog.

Authors:  T Takeya; H Hanafusa; R P Junghans; G Ju; A M Skalka
Journal:  Mol Cell Biol       Date:  1981-11       Impact factor: 4.272

10.  Structural and functional domains of the Rous sarcoma virus transforming protein (pp60src).

Authors:  A D Levinson; S A Courtneidge; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

View more
  73 in total

1.  Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src.

Authors:  M Matsuda; C T Reichman; H Hanafusa
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

2.  Deciphering the cross talk between hnRNP K and c-Src: the c-Src activation domain in hnRNP K is distinct from a second interaction site.

Authors:  Dörte Adolph; Nadine Flach; Katharina Mueller; Dirk H Ostareck; Antje Ostareck-Lederer
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

3.  Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function.

Authors:  B G Bonde; M Sharif; M L Privalsky
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

4.  The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP.

Authors:  Cai-Hong Yun; Kristen E Mengwasser; Angela V Toms; Michele S Woo; Heidi Greulich; Kwok-Kin Wong; Matthew Meyerson; Michael J Eck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-28       Impact factor: 11.205

5.  Tyrosine phosphorylation of a c-Src-like protein is increased in membranes of CD4- CD8- T lymphocytes from lpr/lpr mice.

Authors:  T Katagiri; J P Ting; R Dy; C Prokop; P Cohen; H S Earp
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

6.  Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae.

Authors:  S M Murphy; M Bergman; D O Morgan
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

7.  Conformational snapshots of Tec kinases during signaling.

Authors:  Raji E Joseph; Amy H Andreotti
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

8.  Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src.

Authors:  C Seidel-Dugan; B E Meyer; S M Thomas; J S Brugge
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

9.  Both the SH2 and SH3 domains of human CRK protein are required for neuronal differentiation of PC12 cells.

Authors:  S Tanaka; S Hattori; T Kurata; K Nagashima; Y Fukui; S Nakamura; M Matsuda
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

10.  Mutations in v-Src SH3 and catalytic domains that jointly confer temperature-sensitive transformation with minimal temperature-dependent changes in cellular tyrosine phosphorylation.

Authors:  A D Catling; V J Fincham; M C Frame; B Haefner; J A Wyke
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.